BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10642830)

  • 1. Protection of methamphetamine nigrostriatal toxicity by dietary selenium.
    Kim HC; Jhoo WK; Choi DY; Im DH; Shin EJ; Suh JH; Floyd RA; Bing G
    Brain Res; 1999 Dec; 851(1-2):76-86. PubMed ID: 10642830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model.
    Kim H; Jhoo W; Shin E; Bing G
    Brain Res; 2000 Apr; 862(1-2):247-52. PubMed ID: 10799693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
    Sharma A; Kaur P; Kumar V; Gill KD
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):48-55. PubMed ID: 17519111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
    Ren JP; Zhao YW; Sun XJ
    Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats.
    Sanchez V; Camarero J; O'Shea E; Green AR; Colado MI
    Neuropharmacology; 2003 Mar; 44(4):449-61. PubMed ID: 12646282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B; Dluzen DE
    Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways.
    Hung HC; Lee EH
    Free Radic Biol Med; 1998 Jan; 24(1):76-84. PubMed ID: 9436616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
    Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [WITHDRAWN] Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype.
    Thiruchelvam M; Prokopenko O; Cory-Slechta DA; Richfield EK; Buckley B; Mirochnitchenko O
    J Biol Chem; 2005 Jun; 280(23):22530-9. PubMed ID: 15824117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2004 Oct; 1025():205-20. PubMed ID: 15542719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of system Xc
    Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
    Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.
    Sutphin MS; Buckman TD
    Neurochem Res; 1991 Dec; 16(12):1257-63. PubMed ID: 1784323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum.
    Açikgöz O; Gönenç S; Kayatekin BM; Uysal N; Pekçetin C; Semin I; Güre A
    Brain Res; 1998 Nov; 813(1):200-2. PubMed ID: 9824698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B; Dluzen DE
    Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
    Gao X; Dluzen DE
    Brain Res; 2001 Feb; 892(1):63-9. PubMed ID: 11172749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G; Jenner P
    Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prooxidant properties of ascorbic acid in the nigrostriatal dopaminergic system of C57BL/6 mice.
    Kang MJ; Lee SS; Koh HC
    Toxicology; 2012 Mar; 294(1):1-8. PubMed ID: 22285708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.
    Gajjar TM; Anderson LI; Dluzen DE
    J Neural Transm (Vienna); 2003 Nov; 110(11):1215-24. PubMed ID: 14628187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
    Gao X; Dluzen DE
    Neuroscience; 2001; 103(2):385-94. PubMed ID: 11246153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.